Variant Pharmaceuticals

About:

Variant Pharmaceuticals is a specialty pharmaceutical company utilizing proprietary technologies to create and develop.

Website: http://www.variantpharma.com

Top Investors: INCON Co.

Description:

Variant is a development stage specialty pharmaceutical company utilizing proprietary technologies to create and develop formulations that result in improved therapies for patients. With more than 120 years of biopharmaceutical industry expertise, the Variant team is focused on developing and commercializing products for the treatment of Men’s Health, as well as large and growing markets where current therapies are suboptimal or underdeveloped.

Total Funding Amount:

$14.4M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Weston, Florida, United States

Founded Date:

2014-01-01

Founders:

Shawn Titcomb, Stephen C. Glover

Number of Employees:

1-10

Last Funding Date:

2018-12-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai